Elanco Animal Health Inc ELAN
Elanco Animal Health Incorporated and its subsidiaries (collectively, Elanco, the Company, we, us, or our) is a global leader in animal health, dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets. 10-K, Item 1
- Employees
- 1,000
- Headquarters
- Indianapolis, IN
- CEO
- Jeffrey N. Simmons
- Next results
- around Feb 23, 2027
Where each dollar of revenue went, FY2024
Revenue of $4.4B through the costs to a net profit of $338.0M · income statement of the 10-K
ELAN among Health care peers
Six ratios from the latest 10-K. Each corner is the share of 154 peers the company is above, not a score.
What changed
6 new risk paragraphs. 10-K filed Feb 24, 2026 against Feb 25, 2025.
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
Accounting checks
11 checks on the latest 10-K. Checks, not verdicts.
0facts worth reading about all 11 checks found nothing to note
-
Receivables +8.4% ($805.0M to $873.0M) vs revenue +6.2% ($4.4B to $4.7B), +2.2 pts apart
-
Cash from operations $560.0M vs net income −$232.0M (FY ending Dec 31, 2025)
-
Inventory +10.4% ($1.6B to $1.7B) vs revenue +6.2% ($4.4B to $4.7B), +4.1 pts apart
8 more checks with nothing to note
-
Same auditor in both 10-Ks: Ernst & Young LLP
-
No statement of substantial doubt about going concern
-
No 8-K item 4.02 in the last 2 years
-
No NT 10-K or NT 10-Q in the last 2 years
-
No longer listed: Valuation of goodwill in divestiture. Same as last year: United States (US) sales rebates and discounts
-
No sentence in the 10-K concludes that controls were not effective because of a material weakness
-
No 8-K item 2.06 in the last 2 years
-
No 8-K item 1.03 in the last 2 years
In their words
6 paragraphs in Risk Factors that were not in the 10-K filed Feb 25, 2025. Quoted as filed.
-
Item 1A · new paragraph · not in the 10-K filed Feb 25, 2025 10-K, ITEM 1A
We depend on sophisticated information technology (IT) systems and infrastructure.
-
Item 1A · new paragraph · not in the 10-K filed Feb 25, 2025 10-K, ITEM 1A
We may be required to write down goodwill or other identifiable intangible assets.
-
Item 1A · new paragraph · not in the 10-K filed Feb 25, 2025 10-K, ITEM 1A
We also have a series of cross-currency interest rate swaps (net investment hedges) to help mitigate the impact of currency rate fluctuations on our operations in Switzerland with tenors in August and November of 2026 and February of 2027. As of December 31, 2025, these net investment hedges have generated net losses of approximately…
-
Item 1A · new paragraph · not in the 10-K filed Feb 25, 2025 10-K, ITEM 1A
As a global company, we are subject to various state, federal and international laws and regulations, including regulations relating to the development, quality assurance, manufacturing, importation, distribution, marketing and sale of our products. These laws and regulations, and the approach taken by relevant authorities to enforce…
New risk paragraphs, against peers
Latest 10-K of each, Health care companies closest in revenue
Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.
Financial performance
Last 4 fiscal years · 10-K XBRL
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $4.4B | $4.4B | $4.4B | $4.7B |
| Net income | −$78.0M | −$1.2B | $338.0M | −$232.0M |
| Operating cash flow | $452.0M | $271.0M | $541.0M | $560.0M |
| Free cash flow | $281.0M | $131.0M | $394.0M | $284.0M |
Revenue, FY2016 to FY2025
Ten fiscal years, each from its own 10-K · XBRL · USD
$4.7B ▲ 6.2% in FY2025−$232.0M in FY2025$284.0M ▼ 27.9% in FY2025
Recent filings
2 filings in the last 30 days · SEC EDGAR
-
8-KNov 6, 2026Quarterly results 8-K item 2.02
-
10-QNov 6, 2026Quarterly report (10-Q) period ended Sep 30, 2026
About the company
Elanco Animal Health Inc, Indianapolis, IN · from the 10-K filed Feb 24, 2026
Elanco Animal Health Incorporated and its subsidiaries (collectively, Elanco, the Company, we, us, or our) is a global leader in animal health, dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets. We partner with farmers, pet owners, veterinarians and society to create value and help our customers improve the health of animals in their care, while also making a meaningful impact on the communities we serve.
- Headquarters
- Indianapolis, IN
- Country
- United States
- Reports in
- USD
- Listed on
- NYSE
- Fiscal year ends
- December 31
- Last results
- Nov 6, 2026
Employees, at the top of the page: "As of December 31, 2025, we employed over 1,000 employees in our global R&D and Regulatory Affairs organizations" (10-K). Address and exchange: SEC's company file.
Email alerts
Sources
The 10-K filed Feb 24, 2026 (open at SEC), compared with the 10-K filed Feb 25, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.
Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ELAN/export.csv") into a cell.